1. Introduction {#sec1}
===============

Thioredoxins are a class of ubiquitous, small redox proteins that function as general disulphide reductases by virtue of the reversible oxidation of the two cysteine residues at their conserved active site Cys-Gly-Pro-Cys (CGPC) \[[@bib1],[@bib2]\]. Based on this sequence, two different redox inactive thioredoxins can be generated, in which either both or one of the two cysteine residues are substituted by redox-inactive amino acids such as serine (S) or alanine (A). The variants lacking both cysteines cannot bind their redox substrates nor can perform any redox reaction while the variants lacking one of the two cysteine residues can bind their substrates by a disulphide bond but are unable to reduce them. Even though the vast majority of cellular functions assigned to thioredoxins are dependent on their redox capabilities \[[@bib1],[@bib2]\], there are some exceptions where the role of thioredoxins is independent of the redox cycling of their active site. For instance, in bacteria, *E. coli* TRX-1 is required for filamentous phage assembly \[[@bib3]\] and for supporting phage T7 growth \[[@bib4],[@bib5]\] and both functions are maintained in *E. coli* mutants expressing redox-inactive TRX-1 in which one or both cysteine residues are mutated \[[@bib6],[@bib7]\]. *E. coli* TRX-1 can also work as a chaperone protein both *in vitro* and *in vivo* and this function is independent of a functional redox active site \[[@bib8],[@bib9]\]. Interestingly, the role of thioredoxins as chaperone appear to be conserved in eukaryotes \[[@bib10]\], although the redox-independency of this function has only been additionally demonstrated in plants \[[@bib11],[@bib12]\]. Yet, this may also apply to mammals as redox-inactive TRX-1 is a functional constituent of the "early pregnancy factor", a secreted chaperone complex mainly composed of chaperonin cpn10, required for establishment of pregnancy and embryo implantation \[[@bib13],[@bib14]\]. Other redox-independent functions of thioredoxins in eukaryotes have been reported in yeast, where cytoplasmic TRX-1, complexed with the proteinase inhibitor I^B^2, is needed for vacuole inheritance \[[@bib15]\]. In mammals, TRX-1 works as a monocyte chemoattractant in a redox-dependent manner while it causes monocyte desensitization by a yet unknown redox-independent mechanism \[[@bib16]\]. In addition, TRX-1 variants in which either, but not both, of the cysteine residues at the active site are mutated to serine residues can bind to apoptosis signal-regulating kinase ASK1 and promote its ubiquitination-dependent degradation \[[@bib17]\].

The identification of novel redox-independent functions of thioredoxins in the context of a complete organism is hampered by the embryonic lethal phenotype of knock-out mice lacking *Trx1* or *Trx2* genes \[[@bib18],[@bib19]\]. This phenotype is more likely redox-dependent as mice lacking cytoplasmic or mitochondrial thioredoxin reductase genes, *Trxr1* and *Trxr2*, also die during embryogenesis \[[@bib20],[@bib21]\]. Similarly, attempts to generate viable *trx-2* mutants in zebrafish have also failed \[[@bib22]\]. The nematode model *Caenorhabditis elegans* provides an ideal alternative choice to approach the study of redox-independent functions of thioredoxins as, in this organism, mutants in all thioredoxin genes are viable and have no deleterious phenotype under normal growth conditions \[[@bib23], [@bib24], [@bib25], [@bib26]\]. Indeed, it has been recently shown that *trx-1* null mutant worms fail to avoid the pathogen *Pseudomonas aeruginosa* while worms expressing a TRX-1(SGPC) variant avoid this pathogen as efficiently as wild type worms \[[@bib27]\].

In this study, we report the generation and characterization of a *C. elegans trx-1* mutant that expresses an endogenous redox-inactive TRX-1(SGPS) protein instead of wild type TRX-1(CGPC). This has allowed us to confirm the existence of both TRX-1 redox-dependent and redox-independent functions in this model organism.

2. Results {#sec2}
==========

2.1. *C. elegans* TRX-1 lacking the two active-site cysteine residues is redox-dead {#sec2.1}
-----------------------------------------------------------------------------------

Prior attempting the identification of putative redox-independent roles of *C. elegans* TRX-1, we first aimed to demonstrate that a TRX-1(SGPS) variant ([Fig. 1](#fig1){ref-type="fig"}A), like other metazoan thioredoxins, is indeed redox inactive. For this purpose, we performed the insulin enzymatic assay, which is based on the ability of thioredoxins to use DTT electrons to reduce the disulphide bonds that link together the two insulin polypeptide chains. Once reduced, insulin chains precipitate and the increase in optical density is quantified \[[@bib28]\]. We expressed recombinant TRX-1 as GST fusion protein in *E. coli* and show that, as expected, TRX-1(CGPC) is functional in the insulin assay while TRX-1(SGPS) is unable to reduce insulin chains ([Fig. 1](#fig1){ref-type="fig"}B).Fig. 1***C. elegans* TRX-1(SGPS) is redox dead.** A) Chromatogram of plasmids pGEX-4T-1/CeTRX-1(CGPC) (upper panel) and pGEX-4T-1/CeTRX-1(SGPS) (lower panel) used to generate the respective recombinant proteins TRX-1(CGPC) and TRX-1(SGPS). Identical chromatograms were obtained when sequencing the genomic DNA of *trx-1(null)* and *trx-1(sgps)* nematodes. B) Enzymatic activity of *C. elegans* TRX-1(CGPC) and TRX-1(SGPS) recombinant proteins measured by their capacity to reduce insulin using DTT as electron donor. *Saccharomyces cerevisiae* TRX-1 is used as control.Fig. 1

Next, by CRISPR-Cas9 technology, we generated a *C. elegans* strain in which the endogenous *trx-1* gene is mutated in the same nucleotides as those described for the generation of TRX-1(SGPS) recombinant protein ([Fig. 1](#fig1){ref-type="fig"}A). This redox inactive *trx-1(syb206)* mutant strain \[hereafter designated as *trx-1(sgps),* see [Supplementary Table 1](#appsec1){ref-type="sec"} for strain genotype description\] only expresses a TRX-1(SGPS) protein, that we have demonstrated to be redox inactive in biochemical activity assays ([Fig. 1](#fig1){ref-type="fig"}B) and can then be used to explore which TRX-1 functions are redox-independent.

2.2. *C. elegans* TRX-1 can regulate dauer formation by redox-dependent and redox-independent mechanisms {#sec2.2}
--------------------------------------------------------------------------------------------------------

Under harsh environmental conditions like scarce nutrients, high population density and high temperature, *C. elegans* undergoes a developmental arrest in an endurance larval stage named "*dauer"*, whose formation is mainly regulated by the cGMP, TGFβ and insulin signalling pathways \[[@bib29]\]. Mutations in specific genes of these three pathways result in a dauer-constitutive phenotype as they form dauers under favourable conditions \[[@bib29]\]. While mammalian TRX-1 is ubiquitously expressed, *C. elegans* TRX-1 expression is restricted to worm ASJ sensory neurons \[[@bib23]\], which have been shown to regulate dauer entry and exit \[[@bib30]\]. Although *trx-1(ok1449)* deletion mutants \[hereafter designated as *trx-1(null)*\] do not show defects on dauer formation under favourable conditions, *trx-1(null)* worms with additional mutations in genes that function in any of the three dauer pathways mentioned above display a strong synthetic dauer phenotypes in opposite directions \[[@bib31]\]. Thus, the *trx-1(null)* mutation strongly suppresses the dauer-constitutive phenotype of *daf-28* insulin mutants while robustly increases the dauer-constitutive phenotype of worms harbouring mutations in the *daf-11* gene, encoding a guanylate cyclase \[[@bib31]\] ([Fig. 2](#fig2){ref-type="fig"}A and B). To test whether the *trx-1* synthetic dauer phenotype depends on TRX-1 redox function, we generated animals carrying the *trx-1(sgps)* mutation in *daf-28(sa191)* and *daf-11(m47)* backgrounds, respectively. Interestingly, we found that the TRX-1 dependent dauer formation in *daf-28* mutants remains unchanged in redox-dead *trx-1(sgps)* mutants, showing that this process is redox-independent ([Fig. 2](#fig2){ref-type="fig"}A). In contrast, the enhancement of *daf-11(m47)* dauers upon *trx-1* deficiency was the same in *trx-1(null)* and *trx-1(sgps)* backgrounds, indicating that this synthetic dauer phenotype is redox-dependent ([Fig. 2](#fig2){ref-type="fig"}B). Hence, TRX-1 regulates dauer formation by redox-dependent and redox-independent mechanisms.Fig. 2**Effect of TRX-1 redox activity on *C. elegans* dauer formation and longevity.** Percentage of dauer formation of A) *daf-28(sa191)* and B) *daf-11(m47)* mutants in *trx-1(null)* and *trx-1(sgps)* mutant backgrounds. Bars represent the mean ± S.E.M. of 3 independent experiments, n \> 100 worms per assay and strain. \*\*\**p* \< 0.001 by unpaired *t*-test with Welch\'s correction. ns, no statistically significant difference. Note that *wt*, *trx-1(null)* and *trx-1(sgps)* worms do not form dauers at any temperature. Lifespan at 25 °C of C) *eat-2(ad1116)* and D) *daf-2(e1370)* mutants in *trx-1(null)* and *trx-1(sgps)* backgrounds. Graphs represent Kaplan-Meier survival plots of one representative experiment out of three with similar results ([Supplementary Table 2](#appsec1){ref-type="sec"}, Assay 1). \*\*\**p* \< 0.001 by Log-rank (Mantel-Cox) test compared to *eat-2(ad1116)* or *daf-2(e1370)* single mutants, respectively. No statistically significant difference is found when comparing *trx-1(null)* and *trx-1(sgps)* mutants in *eat-2* or *daf-2* backgrounds.Fig. 2

2.3. *C. elegans* TRX-1 role in longevity is redox-dependent {#sec2.3}
------------------------------------------------------------

In addition of being a dauer-inducing condition, reduced nutrient availability also impacts organismal longevity mainly by regulating the insulin/IGF-1 and mTOR pathways \[[@bib32]\]. Consistently, besides their role in dauer formation, *C. elegans* ASJ neurons have also been implicated in the modulation of worm longevity \[[@bib33]\]. In this context, we have previously shown that *trx-1(null)* mutants are slightly short-lived on their own \[[@bib23]\] but profoundly reduce the extended lifespan of long-lived *daf-2(e1370)* insulin receptor mutants or dietary restricted *eat-2(ad1116)* mutants \[[@bib34]\]. As shown in [Fig. 2](#fig2){ref-type="fig"}C and D and [Supplementary Table 2](#appsec1){ref-type="sec"}, the suppressive effect of *trx-1* deficiency on *daf-2(e1370)* and *eat-2(ad1116)* mutants longevity is redox dependent as the lifespan of *trx-1(spgs); daf-2(e1370)* and *trx-1(sgps); eat-2(ad1116)* double mutants is not significantly different from those of *trx-1(null); daf-2(e1370)* and *trx-1(null); eat-2(ad1116)* worms.

2.4. *C. elegans* TRX-1 controls SKN-1 subcellular localization and *lips-6* expression in a redox-independent manner {#sec2.4}
---------------------------------------------------------------------------------------------------------------------

SKN-1 is the *C. elegans* orthologue of the Nrf2 transcription factor, which is well known to function in stress responses \[[@bib35]\]. During larval and adult stages, SKN-1 is predominantly cytoplasmic but strongly accumulates in nuclei upon stress \[[@bib36]\]. We have previously shown that the *trx-1(null)* mutation induces the nuclear translocation of the SKN-1 transcription factor under non-stress conditions \[[@bib37]\]. This SKN-1 nuclear localization can be rescued by a transgene expressing a TRX-1(SGPS) redox-dead protein, suggesting that the effect of *trx-1* on SKN-1 subcellular localization is redox-independent \[[@bib37]\]. To confirm this finding with the endogenous gene, we generated a worm strain expressing the SKN-1::GFP fluorescent reporter in a *trx-1(sgps)* background which, in contrast to *trx-1(null)* mutants, was unable to target SKN-1::GFP into the nucleus of intestinal cells ([Fig. 3](#fig3){ref-type="fig"}A and B), hence confirming that the regulation of SKN-1 subcellular localization by TRX-1 is redox-independent.Fig. 3**TRX-1 regulates SKN-1 nuclear translocation and LIPS-6 induction in a redox-independent manner.** A) Fluorescence images of *wt*, *trx-1(null)* and *trx-1(sgps)* L4 worms expressing a SKN-1::GFP reporter. The double dots with very bright GFP expression in worms head denote the constitutive expression of the SKN-1::GFP reporter in ASI neurons \[[@bib36]\] and the brownish labelling corresponds to the intestinal autofluorescence. Scale bar 200 μm. B) Percentage of SKN-1::GFP nuclear localization categorically scored and quantified as described in Materials and Methods. Percentages are the average of three biological replicates with n ≥ 50 worms per assay and strain. \*\*\**p* \< 0.001 by Fisher\'s exact test. ns, no statistically significant difference. C) Differential interference contrast (upper panel) and fluorescence (lower panel) images of *wt*, *trx-1(null)* and *trx-1(sgps)* L4 worms expressing a LIPS-6::GFP reporter. Scale bar 100 μm. D) Quantification of LIPS-6::GFP fluorescence intensity (A.B.U., arbitrary brightness units) in whole animals. Dots represent individuals pooled from two independent experiments, n = 25 per assay and strain. \*\*\**p* \< 0.001 by unpaired *t*-test with Welch\'s correction.Fig. 3

Interestingly, despite having SKN-1 in the nucleus, the transcriptional profile of *trx-1(null)* animals is substantially different from the typical SKN-1 stress-dependent transcriptional program. Specifically, transcriptomics analysis of *trx-1(null)* mutants revealed a significant downregulation of genes encoding cuticle components and proteins involved in lipid localization and transport while only three genes, encoding the lipase-related proteins LIPS-6, LIPS-11 and LBP-8, are upregulated \[[@bib37]\]. *lips-6* is the most upregulated gene upon *trx-1* deficiency and this induction is *skn-1* dependent. We asked whether *lips-6* induction in a *trx-1* mutant background is also redox-independent, similarly to SKN-1 subcellular localization. For this purpose, we generated a worm strain expressing GFP under the control of the *lips-6* promoter from the integrated transgene *sybIs6 \[Plips-6::gfp; Pmyo-2::mCherry\]*. Using this transgenic strain, we found that *lips-6* is strongly expressed only in few cells in the vulva and tail, while the rest of the worm tissues are devoid of signal or express *lips-6* very faintly ([Fig. 3](#fig3){ref-type="fig"}C), consistent with previous results using a non-integrated *lips-6* GFP reporter \[[@bib38]\]. However, in a *trx-1(null)* mutant worm, we found a strong induction of the GFP labelling in intestinal cells at the L4 stage which did not occur in a *trx-1(sgps)* mutant background ([Fig. 3](#fig3){ref-type="fig"}C and D), indicating that *lips-6* induction upon *trx-1* deficiency, like SKN-1 subcellular localization, is redox-independent.

2.5. The modulation of *C. elegans* male food-leaving behaviour by TRX-1 is redox-dependent {#sec2.5}
-------------------------------------------------------------------------------------------

We have found that *C. elegans* males have 4-fold increased basal levels of TRX-1 expression in ASJ neurons as compared with their hermaphrodite siblings ([Fig. 4](#fig4){ref-type="fig"}A--D). *C. elegans* males display an active mate-searching behaviour, which is inhibited in the presence of mates \[[@bib39]\]. This behaviour can be quantified using the food-leaving assay, a method that measures the time one isolated adult male takes to abandon a restricted patch of food in search of hermaphrodite mates ([Fig. 4](#fig4){ref-type="fig"}E) \[[@bib40]\]. The circuit underlaying mate-searching has been only partly elucidated \[[@bib41], [@bib42], [@bib43], [@bib44]\]. Interestingly, ASJ neurons have been implicated in male mate-searching behaviour by a *daf-7* dependent mechanism \[[@bib45]\]. Thus, given the TRX-1 sexual dimorphism in ASJ neurons, we asked whether *trx-1* regulates mate-searching behaviour and found that the probability of *trx-1(null)* mutants males to leave a patch of food depleted of mates was significantly reduced ([Fig. 4](#fig4){ref-type="fig"}F). This behaviour appears to be redox-dependent as the time taken by *trx-1(sgps)* males to abandon the food patch does not significantly differ from that of *trx-1(null)* males ([Fig. 4](#fig4){ref-type="fig"}F).Fig. 4***C. elegans* male food-leaving behaviour requires TRX-1 redox activity.** A) Differential interference contrast and fluorescence overlapping image of first day adult hermaphrodite and male worms expressing a TRX-1::GFP reporter. Scale bar 100 μm. Magnification images of B) hermaphrodites and C) males heads to highlight the labelled ASJ neurons (asterisks). D) Quantification of TRX-1::GFP fluorescence intensity (A.B.U., arbitrary brightness units) in ASJ neurons. Dots represent the maximum fluorescence values in ASJ neurons pooled from two independent experiments, n = 20. \*\*\**p* \< 0.001 by unpaired *t*-test with Welch\'s correction. E) Graphical scheme of *C. elegans* male food-leaving behaviour. F) Probability of leaving (P~L~) of *wt*, *trx-1(null)* and *trx-1(sgps)* first day adult males. Bars represent the mean ± S.E.M. of 6 independent experiments, n = 20 worms per assay for *wt* and *trx-1(null)* males and 4 independent experiments, n = 20 per assay for *trx-1(sgps)* males. Maximum likelihood statistical analysis was used to compare P~L~ values. \*\**p* \< 0.01; \*\*\**p* \< 0.001; ns, no statistically significant difference.Fig. 4

3. Discussion {#sec3}
=============

Since their discovery in *E. coli* \[[@bib46]\], thioredoxins have been found in virtually all organisms investigated. By far, most thioredoxin functions have been found to rely on their redox capabilities, although redox-independent functions have also been reported. The identification of redox-independent functions of thioredoxins may have been greatly underestimated as many thioredoxin functions have not yet been tested using redox-inactive variants. Furthermore, the embryonic lethal phenotypes of thioredoxin knock-out mice and zebrafish \[[@bib18],[@bib19],[@bib22]\] present an additional hurdle to the use of vertebrate models in the identification of novel redox-independent thioredoxin functions. In this work, we validate *C. elegans* as a suitable model to address this question, taking advantage that a null mutation in worm *trx-1* gene does not cause any deleterious phenotype \[[@bib23]\].

A transcriptomic analysis of *trx-1(null)* mutants revealed that *trx-1* deficiency causes upregulation of genes involved in lipid mobilization and downregulation of genes required for lipid localization and transport \[[@bib37]\], consistent with a perceived status of starvation. TRX-1 is expressed in ASJ neurons where it regulates dauer formation and worm longevity, traits that are modulated by nutrient availability. Indeed, the *trx-1* gene is responsive to nutrient availability as TRX-1 levels are robustly increased upon starvation at any developmental stage, including dauer ([Supplementary Fig. 1](#appsec1){ref-type="sec"}). Interestingly, we have found that the function of TRX-1 in these nutrient availability related traits is dual: a) TRX-1 redox activity is needed for *daf-2* and *eat-2* mutants extended lifespan, the enhancement of dauer formation in a *daf-11* mutant background and male food-leaving behaviour whereas b) the decrease of dauer formation in *daf-28* insulin mutants and the SKN-1 dependent induction of *lips-6* expression upon *trx-1* deficiency is redox-independent. Although insulins are well known thioredoxin substrates \[[@bib28]\], the redox-independent synthetic phenotype of *trx-1* and *daf-28* mutants suggests that TRX-1 may act in regulating *daf-28* expression levels, as previously reported \[[@bib31]\], or secretion. On the other hand, impairment of DAF-28 secretion has been associated with increased SKN-1 activity \[[@bib47]\]. Given that *lips-6* is the most upregulated gene in *trx-1(null)* mutants in a SKN-1 dependent manner, it is tempting to speculate that these two redox-independent functions of TRX-1 may be mechanistically linked. Indeed, bidirectional signalling between ASJ neurons and the intestine has been previously reported in other nutrient-dependent traits like cold-acclimation, L1 and dauer diapause or foraging behaviour \[[@bib48], [@bib49], [@bib50]\]. Further support for using *C. elegans* as model to identify novel redox-independent functions of TRX-1 comes from the recent finding that TRX-1 mediates worm avoidance to *Pseudomonas aeuroginosa* by responding to nitric oxide produced by this pathogen \[[@bib27]\]. While *trx-1(null)* mutants fail to avoid *Pseudomonas*, a worm strain producing an endogenous redox-dead TRX-1(CGPS) avoids the pathogen as efficiently as wild type animals. TRX-3 is another *C. elegans* thioredoxin expressed exclusively in the intestine which is strongly induced upon exposure to different worm pathogens and, consistently, increased levels of TRX-3 provide partial protection to infection \[[@bib25]\]. Null *trx-3* mutants are viable, thus allowing to test whether TRX-3 role in pathogen resistance, like TRX-1, is also independent of its redox activity.

In summary, our results provide a proof of concept for the use of *C. elegans* as a model of choice not only to identify novel redox-independent functions of metazoan thioredoxins but, given the genetic amenability of this model, to delve deeper into their molecular mechanisms. Importantly, in addition to the *trx-1* and *trx-3* genes discussed above, three more thioredoxin-encoding genes (*trx-2*, *trx-4* and *trx-5*) are present in *C. elegans* and, interestingly, putative null mutants of these three genes are also viable under normal growth conditions \[[@bib24],[@bib26]\] thus expanding the potential of the model in this unexplored scenario of redox-independent functions of thioredoxins.

4. Materials and methods {#sec4}
========================

4.1. Recombinant protein purification and enzymatic activity assay {#sec4.1}
------------------------------------------------------------------

The plasmid pGEX-4T-1/CeTRX-1(SGPS) was obtained by site-directed mutagenesis of *trx-1* active site using as bait a pGEX-4T-1/CeTRX-1(CGPC) construct \[[@bib23]\] and the mutagenic primers 5′-TCTATGCAACTTGGT**[C]{.ul}**CGGACCAT**[C]{.ul}**CAAAGCAATTGCACC-3´ (forward) and 5′-GGTGCAATTGCTTTG**[G]{.ul}**ATGGTCCG**[G]{.ul}**ACCAAGTTGCATAGA-3′(reverse), following manufacturer\'s instructions (QuickChange II Site-Directed Mutagenesis Kit, Agilent). Mutagenesis was confirmed by sequencing of the pGEX-4T-1/CeTRX-1(SGPS) plasmid in both directions ([Fig. 1](#fig1){ref-type="fig"}A).

For recombinant protein purification, *E. coli* BL21(DE3) transformed with the corresponding pGEX-4T-1/CeTRX1 construct were inoculated in LB medium containing 0.1 mg ampicillin/ml and grown at 37 °C until Abs~600~ = 0.5. Then the recombinant protein was induced by the addition 0.5 mM isopropyl-1-thio-β-[d]{.smallcaps}-galatopyranoside, and growth was continued at 37 °C for 3.5 h. Cells were collected by centrifugation and resuspended in phosphate buffer saline (PBS) containing 0.5 mg lysozyme/ml and 0.1 μg DNase I/ml (Lysozyme and DNase I from Sigma). Then cells were lysed by sonication and the homogenate was clarified by centrifugation at 10,000×*g* for 30 min. The cell free extract was filtered and loaded onto a Glutathione Sepharose 4B™ column (Amersham Biosciences) equilibrated with PBS. The column was washed with PBS and the recombinant protein was eluted with PBS containing 10 mM GSH. To separate the GST-tag from the TRX-1 protein, 1 unit of thrombin/ml was added to the purified recombinant protein, incubated for 2 h at room temperature and dialyzed against PBS. Finally, the sample was passed through a Glutathione Sepharose 4B™ column buffered with PBS and the flow-through containing TRX-1 protein was collected. Protein concentration was determined according with the molar extinction coefficient at 280 nm for TRX1(CGPC) (10,220 M^−1^ cm^−1^) and for TRX1(SXXS) (10,095 M^−1^ cm^−1^). The insulin reduction assay for redox activity of thioredoxin was monitored in an Ultrospect 4000 UV/Visible Spectrophotometer (Pharmacia Biotech) by the increase of light scattering at 600 nm. Assay conditions were 20 mM TrisHCl pH 7.5, 1 mM EDTA, 1 mg porcine insulin/ml (Sigma), 5 μM TRX-1 and the reaction was initiated by addition of 1 mM DTT.

4.2. *C. elegans* strains {#sec4.2}
-------------------------

The standard methods used for culturing and maintenance of *C. elegans* were as described \[[@bib51]\]. A list of all strains used and generated in this study is provided in [Supplementary Table 1](#appsec1){ref-type="sec"}. The strain PHX206, *trx-1(syb206)* II was generated at SunyBiotech (<http://www.sunybiotech.com>) by CRISPR-Cas9 using the sgRNAs sg1-GATTTCTATGCAACTTGGTGCGG and sg2-CCATGCAAAGCAATTGCACCATT and the editing was confirmed by sequencing the *trx-1* gene in both directions. All VZ strains are 6x backcrossed with N2 wild type. Unless otherwise noted, all experiments were performed on synchronized worms generated by allowing 10 to 15 gravid hermaphrodites to lay eggs during two to three hours on seeded plates at 20 °C.

4.3. Analysis of dauer formation {#sec4.3}
--------------------------------

For dauer formation, worms were incubated at the respective assay temperatures after synchronized egg-lay. Dauers and non-dauers (L3, L4 and adult animals) on the agar and side of the plate were counted after 50 h at 25 °C for the *daf-28* dauer assay and after 96 h at 16 °C for the *daf-11* dauer assay. In all cases, dauers were discriminated from non-dauers based on the absence of pharyngeal pumping and radial shrinkage of the body \[[@bib52]\]. More than 100 animals were counted in three independent experiments per genotype.

4.4. Lifespan determinations {#sec4.4}
----------------------------

Strains were synchronized by hypochlorite treatment of gravid adults and the progeny was grown during two generations at 16 °C. F2 L4 animals were shifted to 25 °C (t = 0). During the first week, animals were transferred to a fresh plate every two days. Afterwards, worms were transferred at least once per week and scored every two days until death. Animals lost or dead by non-physiological causes were censored. GraphPad Prism 7 (Version 7.00) was used for statistical analysis and graphs. Survival curves were generated using the product-limit method of Kaplan and Meier. The log-rank (Mantel-Cox) test was used to evaluate differences in survival and *p* values lower than 0.05 were considered as significant.

4.5. SKN-1::GFP nuclear localization {#sec4.5}
------------------------------------

To visualize SKN-1 expression, synchronized L4 worms expressing a SKN-1B/C::GFP fusion protein (abbreviated as SKN-1::GFP) were washed from plates and anesthetized with 50 mM tetramisole. Anesthetized worms were mounted on 2% agarose pads and visualized and imaged using an Olympus Fluoview fv3000 confocal microscope. For quantification of SKN-1::GFP localization, the percentage of intestinal SKN-1::GFP nuclear localization was categorically scored as follows: score 0: no localization; score 1: marginal posterior or anterior intestinal localization; score 2: expanded posterior or anterior intestinal localization; score 3: posterior and anterior intestinal localization; score 4: localization throughout the entire intestine (modified from Ref. \[[@bib53]\]).

4.6. LIPS-6::GFP and TRX-1::GFP expression {#sec4.6}
------------------------------------------

Synchronized L4 worms (48 h after egg-lay) expressing a LIPS-6::GFP fusion protein and synchronized first day adult worms (72 h after egg-lay) expressing a TRX-1::GFP fusion protein were blindly picked at the stereoscope and anesthetized with 10 mM levamisole. Anesthesized worms were mounted on 2% agarose pads and visualized using an Olympus BX61 fluorescence microscope equipped with a DP72 digital camera coupled to CellSens Software for image acquisition and analysis. ImageJ Software (NIH) was used to quantify the fluorescence of the worms either in the whole body (for LIPS-6::GFP) or in ASJ neurons (for TRX-1::GFP).

4.7. Male food-leaving behaviour {#sec4.7}
--------------------------------

The assay was performed and scored as previously described \[[@bib40]\] with some modifications. A population of 20 L4 males were transferred to new plates the day before the assay (afternoon) and grown overnight at 20 °C. The assay was performed by placing each male individually in a Petri dish (9 cm in diameter and 12 ml of agar) in the center of a 15 μl (9 mm diameter approximately) patch of food (*E. coli* OP50 seeded the evening before). Plates were kept at 20 °C during the 24 h assay, and the proportion of males that had left the food was scored at four time points (at 2 h, 5 h, 8 h and 24 h). A male was considered a leaver and left censored if at the scoring time point it had reached a 1 cm distance from the edge of the plate.
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